Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCqs New C.h.y.f Regulatory News (NCYF)

Share Price Information for Cqs New C.h.y.f (NCYF)

Share Price is delayed by 15 minutes
Get Live Data
50.80    0.40 (0.79%)
Bid:
50.60
Ask:
51.00
Spread: 0.40 (0.791%)
Market Cap: £347.93m
NCYF Live PriceLast checked at - London Stock Exchange

Intraday Cqs New C.h.y.f Share Chart

Interim Report

27 Feb 2025 07:00

RNS Number : 5937Y
CQS New City High Yield Fund Ltd
27 February 2025
 

27 February 2025

CQS New City High Yield Fund Limited("NCYF" or the "Company")

 Interim Report for the six months ended 31 December 2024

CQS NEW CITY HIGH YIELD FUND LIMITED (the Company) has published its interim report. A copy can shortly be found on the Company's website https://ncim.co.uk/cqs-new-city-high-yield-fund-ltd/, and on the National Storage Mechanism (https://data.fca.org.uk/#/nsm/nationalstoragemechanism) and will also be provided to those shareholders who have requested a printed or electronic copy.

Highlights:

· NAV total return of 3.58% for the six months ended 31 December 2024

· Ordinary share price total return of 2.91% for the six months ended 31 December 2024

· Dividend yield of 8.79%, based on dividends at an annualised rate of 4.50 pence and an ordinary share price of 51.20 pence as at 31 December 2024

· Ordinary share price at a premium of 4.88% as at 31 December 2024

· £13,363,000 of equity issued during the six months to 31 December 2024

Caroline Hitch, Chair of CQS New City High Yield Fund Limited, commented: "It is testament to the strength of our strategy that we have delivered a 3.58% NAV total return despite a turbulent bond market during the period. The share price performed well and we remain one of the very few listed investment trusts trading at a premium to NAV. This allowed us to issue over £13 million of equity, which the Manager has invested into a diverse range of sectors and stocks. The Board remains focused on providing additional value to shareholders through its dividend payments, which is reflected in the Company's long track record of increasing dividends since 2007."

Ian "Franco" Francis, Portfolio Manager at CQS New City High Yield Fund Limited, commented: "It was a busy period for the portfolio as a number of companies sought to refinance their bonds ahead of the UK budget in October, which enabled us to re-invest in the new financing rounds of those companies with strong fundamentals and attractive yields as well as identify exciting opportunities in a number of other securities. Despite the prevailing uncertainty across fixed interest markets, we remain comfortable about both the existing portfolio of diversified investments and our ability to capitalise on new issuances, supporting our continued efforts to deliver an attractive yield and dividend growth for shareholders."

-ENDS-

 

For Further Information

 

CQS New City High Yield Fund Limited 

T: +44 (0) 20 7201 6900

E: contactncim@cqsm.com

 

Singer Capital Markets

 

T: +44 (0) 20 7496 3000

 

Cardew Group

Tania Wild

Henry Crane

Liam Kline

 

 

T: +44 (0) 20 7930 0777

M: +44 (0) 7425 536 903

M: +44 (0) 7918 207 157

M :+44 (0) 7827 130429

E: ncyf@cardewgroup.com

https://www.cardewgroup.com/

 

Company Secretary and Administrator

BNP Paribas S.A., Jersey Branch

Edward Kazibwe

 

T: +44 (0) 1534 813 913

 

About CQS New City High Yield Fund Limited

 

CQS New City High Yield Fund Limited aims to provide investors with a high dividend yield and the potential for capital growth by investing in high-yielding, fixed interest securities. These include, but are not limited to, preference shares, loan stocks, corporate bonds (convertible and/or redeemable) and government stocks. The Company also invests in equities and other income-yielding securities.

Since the Fund's launch in 2007, the Board has increased the level of dividends paid every year. As at 31 December 2024, the Company's dividend yield was 8.79%. In addition to quarterly dividend payments, the Fund seeks to deliver investors access to a high-income asset class across a well-diversified portfolio with low duration to help mitigate interest rate risk.

Further information can be found on the Company's website at https://ncim.co.uk/cqs-new-city-high-yield-fund-ltd/

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IR FLFLDFEIRFIE
Date   Source Headline
12th Dec 202412:36 pmRNSNet Asset Value(s)
12th Dec 202410:04 amRNSBlock Listing Approval
11th Dec 20243:49 pmRNSBlock Listing Application (replacement)
11th Dec 202412:33 pmRNSNet Asset Value(s)
10th Dec 202412:52 pmRNSNet Asset Value(s)
9th Dec 20241:34 pmRNSNet Asset Value(s)
9th Dec 20249:23 amRNSBlock Listing Application
6th Dec 20242:09 pmRNSNet Asset Value(s)
5th Dec 202412:43 pmRNSNet Asset Value(s)
4th Dec 202412:39 pmRNSNet Asset Value(s)
3rd Dec 20244:02 pmRNSAppointment of Non-Executive Director
3rd Dec 20241:48 pmRNSDirectorate Change
3rd Dec 20241:31 pmRNSNet Asset Value(s)
3rd Dec 20241:26 pmRNSResult of AGM
2nd Dec 20244:53 pmRNSIssue of Equity
2nd Dec 202412:47 pmRNSNet Asset Value(s)
2nd Dec 202411:21 amRNSTotal Voting Rights
29th Nov 20241:16 pmRNSNet Asset Value(s)
28th Nov 202412:55 pmRNSNet Asset Value(s)
27th Nov 20243:05 pmRNSNet Asset Value(s)
26th Nov 202412:50 pmRNSNet Asset Value(s)
25th Nov 20241:27 pmRNSNet Asset Value(s)
22nd Nov 20244:50 pmRNSIssue of Equity
22nd Nov 20241:13 pmRNSNet Asset Value(s)
21st Nov 202412:22 pmRNSNet Asset Value(s)
21st Nov 20249:19 amRNSMonthly Factsheet as at 31 October 2024
20th Nov 202412:06 pmRNSNet Asset Value(s)
19th Nov 20241:17 pmRNSNet Asset Value(s)
18th Nov 20243:46 pmRNSNet Asset Value(s)
18th Nov 20247:00 amRNSBlock listing Interim Review
15th Nov 20241:09 pmRNSNet Asset Value(s)
14th Nov 20241:28 pmRNSNet Asset Value(s)
13th Nov 20241:23 pmRNSNet Asset Value(s)
12th Nov 20244:55 pmRNSIssue of Equity
12th Nov 20241:13 pmRNSNet Asset Value(s)
11th Nov 20241:10 pmRNSNet Asset Value(s)
11th Nov 20247:00 amRNSInvestor Presentation via Investor Meet Company
8th Nov 20242:44 pmRNSNet Asset Value(s)
7th Nov 20241:02 pmRNSNet Asset Value(s)
6th Nov 20241:56 pmRNSNet Asset Value(s)
5th Nov 202412:38 pmRNSNet Asset Value(s)
4th Nov 20241:43 pmRNSNet Asset Value(s)
1st Nov 20241:16 pmRNSNet Asset Value(s)
1st Nov 202411:32 amRNSTotal Voting Rights
31st Oct 20241:25 pmRNSNet Asset Value(s)
30th Oct 20241:38 pmRNSNet Asset Value(s)
29th Oct 20241:00 pmRNSNet Asset Value(s)
28th Oct 202412:03 pmRNSNet Asset Value(s)
28th Oct 20247:00 amRNSMonthly Factsheet as at 30 September 2024
25th Oct 20244:12 pmRNSIssue of Equity

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.